In Brief: Nitinol Medical Technologies:
This article was originally published in The Gray Sheet
Nitinol Medical Technologies: Gains 510(k) clearance to market its Simon Nitinol Filter for implantation through the subclavian vein. The "thermal shape-memory nitinol vena cava filter designed to prevent pulmonary embolisms" has been approved for implantation via the leg, neck and arm since 1990...
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.